Haleon sales sniffles calls for tough medicine
The £28 bln Sensodyne maker lost nearly £5 bln in market value on weak revenue growth. One-off hits in Brazil and China show expansion is risky. And with over 30% of sales in the sickly US market, …
The £28 bln Sensodyne maker lost nearly £5 bln in market value on weak revenue growth. One-off hits in Brazil and China show expansion is risky. And with over 30% of sales in the sickly US market, …